Stocks To Watch on August 1, 2025: Swiggy, Adani Enterprises, Coal India, and Others

On Thursday, the NSE Nifty 50 ended 87 points down at 24,768, while the BSE Sensex closed 296 points lower at 81,185. This morning, Gift Nifty was trading around 24,725, nearly 146 points below the Nifty futures’ previous close, signaling a possible gap-down start for Indian indices.

Here are the top stocks to watch on August 1, 2025.

Adani Enterprises Sees A 44.9% Decline in Net Profit

Adani Enterprises share price (NSE: ADANIENT) may come under pressure after the company posted a 44.9% YoY decline in net profit to ₹976.48 crore for Q1FY26. Revenue from operations also fell 13.96% YoY to ₹21,916.20 crore, as demand across segments softened.

Maruti Suzuki Sees 1.7% YoY Growth in Net Profits

Maruti Suzuki share price (NSE: MARUTI) may trade positively after the auto major reported a 1.7% YoY rise in net profit at ₹3,712 crore. A sharp increase in other income to ₹1,823 crore supported the performance, despite muted domestic demand.

Ambuja Cements Sees 23% Growth in Net Profits

Ambuja Cements share price (NSE: AMBUJACEM) could gain after reporting a 23.1% YoY jump in net profit at ₹788 crore, with total profit reaching ₹970 crore. Revenue growth and cost efficiencies helped beat street expectations.

Coal India Records 20% Decline in Net Profits

Coal India share price (NSE: COALINDIA) may weaken after the company posted a 20.19% YoY fall in net profit at ₹8,734.17 crore, while revenue declined 4.43% to ₹35,842 crore due to lower coal demand.

Swiggy Records 53.97% Growth in Revenue, But Profit Plummets

Swiggy may attract mixed views from investors as its revenue surged 53.97% YoY to ₹4,961 crore, but net loss widened to ₹1,197 crore. The quick commerce unit, Instamart, remains a drag on profitability.

Dabur India Beats Estimates on Marginal Profit Rise

Dabur India share price (NSE: DABUR) may remain steady after posting a 2.82% YoY rise in net profit to ₹508.29 crore, with revenue up slightly to ₹3,404.58 crore. EBITDA stood at ₹667.8 crore.

Mankind Pharma Profit Drops 18.1% YoY but Revenue Surges

Mankind Pharma share price (NSE: MANKIND) might trade cautiously after a 18.1% YoY decline in net profit to ₹444.6 crore, though revenue rose 24.5% YoY to ₹3,570 crore, driven by strong domestic demand.

Read more: Will IT Software Companies in India Feel the Heat of Trump’s Tariffs?

Conclusion

As markets open amid global uncertainty, investors should keep an eye on earnings-driven stock movements. From profit beats to margin pressure, Q1FY26 has brought mixed signals. Ensure your demat accountis active to make timely and informed investment decisions as new opportunities emerge.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

 Investments in the securities market are subject to market risks, read all the related documents carefully before investing.